Welcome everyone! Please remember to remain on mute during the presentations. Feel free to introduce yourself in the chat and to add questions here as they arise. You will also have a chance to unmute and ask questions during the discussion. The recording and slides from this meeting will be shared via email and on the website!

Greetings everyone, I am Patricia Jodrey, Child Health Lead, MCHN Office, USAID Washington

Hi - Nancy Bolan, Newborn Health Team, MCHN Team, USAID Washington

Dr. Victor Nyange, Senior Manager Health and Impact, Living Goods Kenya

Hello, Elizabeth Berryman community health systems Malaria Consortium. I didn't sign up for this subgroup so I am wondering if I should step out

Hello - I am Jane Briggs, lead on MNCH in the USAID Medicines Technologies and Pharmaceutical Services MTaPS program implemented by MSH and partners

Please stay Elizabeth - there is no restriction to participate in these meetings

@Elizabeth - your view points are very important

Der Elizabeth,The sub-group meeting is the first part.The dissemination of the Amox-Gent Call to Action paper will follow shortly.I reckon you might want to participate in that session.

Patrick Gaparayi, Supply Chain Manager, UNICEF Supply Division, Copenhagen

Dr Ajay Gambhir neonatologist & paed at saroj super speciality hospital new delhi represent ngo/ civil society

Beth Yeager, Deputy Director USAID Promoting the Quality of Medicines Plus Program led by USP

Ellie Bahirai, Director, Health Elements (Core MCH), PQM+

Malaria Consortium can share our experience of planning commodities for SMC which is a community led intervention where we work at scale.

That's great, thank you Elizabeth! Feel free to email the co-chairs or childhealthtaskforce@jsi.com

Please feel free to post your questions in the chatbox while the presentation is going on.

Dyness Kasungami, Director, Child Health Task Force Secretariat at JSI.

Hello everyone. Simon Berry here, ORS/Zinc Co-pack Alliance (ORSZCA).

We welcome all the members to share your great work you are doing, a guidance to disseminate, lessons learned, etc. through this forum. We are aiming at organizing one event every quarter, but we will continue to rely on everyone of you.

Greetings, all. John Borrazzo, Child Health Director, MOMENTUM Country and Global Leadership (MCGL), Washington DC

Emmanuel d'Harcourt, formerly of IRC, Vital Strategies, HKI, currently on sabbatical in Senegal.

Ok

Good morning, afternoon, evening! Trish Coffey, Program Advisor and Director, Health Technologies for Women and Children portfolio and Asset Tracker project, PATH, Seattle USA

Really appreciate the consultation. Will be interested to read the paper and in particular see any analysis of why common-sense, proven strategies are not currently being widely implemented; ideally including a political economy perspective (what are the power issues/incentives that prevent governments and other actors for taking action)

Joseph Monehin, Senior Child Health Advisor, USAID/Co-Chair, Newborn and Child Health Commodities Sub-group, Child Health Task Force.

Hello everyone, Fay Venegas from PFSCM. Excited to be talking about newborn and child health again!

Are formulation and dosages specified for child and newborn the paper?

So this includes supporting national manufacture as an investment to reduce importation?

Oh I see that thanks great

please share the full document with us

The draft document will be shared for comment after the meeting

This is my first time to engage with this work. Why were Amoxicillin and Gentamicin chosen as the focus for this work?

You can learn more about Child Survival Action by reading our vision document: https://www.childhealthtaskforce.org/resources/action-plan/2022/child-survival-action-vision-narrative-document

This is the link to the consultative meetings https://www.childhealthtaskforce.org/events/2022/05/improving-uptake-amoxicillin-and-gentamicin-three-part-consultation

I am from Afghanistan and we have to work for zero-dose children. If someone help me to find any document about approach to reach these zero-dose children would be appreciated

The draft of the paper will be shared after this meeting and you are invited to provide any feedback to the CHTF e mail

The GF recommendation is a great step forward but the overall budget envelope for GF support has not increased. So there is more choice but less funds as I understand it.

childhealthtaskforce@jsi.com

It seems to be a great document and very much needed thanks.

I welcome the focus on “low hanging fruit” and on “actionable tasks”. Does conflict with the iCCM ie with those advocating a holistic approach?

Hi, the message of the call for action refers to general problems with access but also especifically for amoxi and gentamicin. Are there some examples of how programmes have succeded in resolving barriers and sustaining implementation (both generally for PHC and more specifically for sepsis)? It would be informative to refer to such cases.

The taxation waivers and support to local manufacture was raised in Ethiopia so great to see that.

couldn't agree more about the dispersible tablets

But can there be a global supply of right-formulated amoxicillin? In my experience it seems the wheel has to be reinvented in each country when the needs in terms of formulation are very similar

Thanks so much!

There is some SBC work done to address issues around AMR is that what you meant by SBC engagement, a focus on adherence and health seeking behaviour or more advocacy by communities to address drug shortages?

PQM+ will be doing some work around SBC to raise awareness of SF medicines and will address AMR as part of those key messages and interventions to address them.

Thank you Joseph and Jane.

When we engage with countries, would we need to contextualize the message for each country? I understand countries are at different stages in terms of commodities availability, guidelines updates, financing etc

thank you Joseph

childhealthtaskforce@jsi.com

please share any feedback and further comments

I congratulate all participants for this important meeting in the proper care of our community, so I ask GF to make more effort to help African countries to organize more for better availability of some products of the iCCM to meet the needs of our populationsthank you

Thank you to the subgroup for spearheading the consultations and draft call to action. Important and timely work.

Thanks for the presentation, and for the consultation

Thank you everyone. This was very useful.